Cangene Corporation CNJ Financial and Strategic SWOT Analysis Review

We are sorry but this premium report expired!

This market research, not available anymore on the publisher's website, was withdrawn from our database.

To get an alternative report, you can either :

  • Have a look at the list of documents hereafter
  • Launch a new search below

Find all the market research you need - instantly, in one place.

+1.2 Million Research Documents & Statistics +200,000 Trusted Public Sources 350 Industries With Global Coverage

DOWNLOAD THESE REPORTS NOW!

Biologic Therapeutic Drugs: Technologies and Global Markets

Biologic Therapeutic Drugs: Technologies and Global Markets

  • $ 6 650
  • Industry report
  • by BCC Research
  • Dec 2014
  • 172 pages

REPORT HIGHLIGHTS The global biologics market totaled $200.6 billion in 2013 and is expected to grow to nearly $234 billion in 2014. The total market is expected to grow to $386.7 billion by the end of 2019 at compound annual growth rate (CAGR) of 10.6%. This report provides: An overview of the global ...

Industries: Biopharmaceutical | Countries: World

Zhenxing Biopharmaceutical & Chemical Inc

Zhenxing Biopharmaceutical & Chemical Inc

  • $ 55
  • Company report
  • by Wright Investors' Service
  • December 2014
  • 55 pages

A textual analysis of the financial results for Zhenxing Biopharmaceutical & Chemical Inc compared to selected competitors. Also included are quantitative analyses of the company's financial statements, extensive ratio analyses and up to 10-year history of sales, earnings, dividends and security pricing. ...

Industries: Biopharmaceutical

RegeneRx Biopharmaceuticals, Inc.

RegeneRx Biopharmaceuticals, Inc.

  • $ 55
  • Company report
  • by Wright Investors' Service
  • December 2014
  • 56 pages

A textual analysis of the financial results for RegeneRx Biopharmaceuticals, Inc. compared to selected competitors. Also included are quantitative analyses of the company's financial statements, extensive ratio analyses and up to 10-year history of sales, earnings, dividends and security pricing. A ...

Industries: Biopharmaceutical

Accentia Biopharmaceuticals, Inc.

Accentia Biopharmaceuticals, Inc.

  • $ 55
  • Company report
  • by Wright Investors' Service
  • December 2014
  • 55 pages

A textual analysis of the financial results for Accentia Biopharmaceuticals, Inc. compared to selected competitors. Also included are quantitative analyses of the company's financial statements, extensive ratio analyses and up to 10-year history of sales, earnings, dividends and security pricing. A ...

Industries: Biopharmaceutical

XTL BIopharmaceuticals Limited

XTL BIopharmaceuticals Limited

  • $ 55
  • Company report
  • by Wright Investors' Service
  • December 2014
  • 56 pages

A textual analysis of the financial results for XTL BIopharmaceuticals Limited compared to selected competitors. Also included are quantitative analyses of the company's financial statements, extensive ratio analyses and up to 10-year history of sales, earnings, dividends and security pricing. A business ...

Industries: Biopharmaceutical | Countries: Israel

Keryx Biopharmaceuticals, Inc.

Keryx Biopharmaceuticals, Inc.

  • $ 55
  • Company report
  • by Wright Investors' Service
  • December 2014
  • 55 pages

A textual analysis of the financial results for Keryx Biopharmaceuticals, Inc. compared to selected competitors. Also included are quantitative analyses of the company's financial statements, extensive ratio analyses and up to 10-year history of sales, earnings, dividends and security pricing. A business ...

Industries: Biopharmaceutical

Sun Biomedical Limited

Sun Biomedical Limited

  • $ 55
  • Company report
  • by Wright Investors' Service
  • December 2014
  • 53 pages

A textual analysis of the financial results for Sun Biomedical Limited compared to selected competitors. Also included are quantitative analyses of the company's financial statements, extensive ratio analyses and up to 10-year history of sales, earnings, dividends and security pricing. A business description ...

Industries: Biopharmaceutical

Calypte Biomedical Corporation

Calypte Biomedical Corporation

  • $ 55
  • Company report
  • by Wright Investors' Service
  • December 2014
  • 56 pages

A textual analysis of the financial results for Calypte Biomedical Corporation compared to selected competitors. Also included are quantitative analyses of the company's financial statements, extensive ratio analyses and up to 10-year history of sales, earnings, dividends and security pricing. A business ...

Industries: Biopharmaceutical

Calypte Biomedical Corporation (CBMC) - Product Pipeline Analysis, 2014 Update

Calypte Biomedical Corporation (CBMC) - Product Pipeline Analysis, 2014 Update

  • $ 750
  • Company report
  • by Global Data
  • December 2014
  • 23 pages

Summary Calypte Biomedical Corporation (Calypte) is a diagnostic service provider. The company carries out development, manufacturing and marketing of in-vitro testing algorithms for improved diagnosis of HIV infection and other chronic diseases. Its products include rapid tests and traditional EIA diagnostic ...

Industries: Biopharmaceutical | Countries: United States

RegeneRx Biopharmaceuticals, Inc. - Product Pipeline Review - 2014

RegeneRx Biopharmaceuticals, Inc. - Product Pipeline Review - 2014

  • $ 1 500
  • Industry report
  • by Global Markets Direct
  • December 2014
  • 28 pages

RegeneRx Biopharmaceuticals, Inc. - Product Pipeline Review - 2014 Summary Global Markets Direct's, ‘RegeneRx Biopharmaceuticals, Inc. - Product Pipeline Review - 2014', provides an overview of the RegeneRx Biopharmaceuticals, Inc.'s pharmaceutical research and development focus. This report provides ...

Industries: Biopharmaceutical | Countries: World

24/7 Customer Service

You can call our customer service 24 hours a day / 7 days a week

  • +1 718 618 4302

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.